Dr Reddy’s to acquire allergy brands from Glenmark
Premium
1 December 2020
Indian pharmaceutical company Dr Reddy’s Laboratories is acquiring a portfolio of allergy remedies from Glenmark Pharmaceuticals in Russia, Ukraine, Kazakhstan and Uzbekistan.